Company lists · Data refreshed September 2026
Top 22 Immunotherapy venture capital companies based in Germany
RevenueBase identified 48 immunotherapy venture capital companies headquartered in Germany as of September 2026 and tracks 5,804 professional contacts across them, including 3,509 with verified work emails and 594 with mobile numbers. Munich is the largest hub.
This list covers immunotherapy venture capital companies headquartered in Germany, matched on what each company actually does as described in its own words. Ranked by team size, largest first. Every row shows the company's own description, its RevenueBase Smart Search rating, and when it was last checked. Data refreshed September 3, 2026.
Published by RevenueBase, a B2B data infrastructure company. This list was built with RevenueBase Smart Search, the natural-language company search RevenueBase customers use to build their own targeted lists and unlock verified emails and direct dials at the companies on them. How these lists are built and judged.
The 22 largest immunotherapy venture capital companies based in Germany
Ranked by team size| # | Company | Contacts | |||
|---|---|---|---|---|---|
| 1 | 4,503 contacts → | ||||
Partial evidence “Biopharmaceutical New Technologies (BioNTech) is a global biotechnology company aspiring to translate science into survival by developing new immunotherapies utilizing the full…” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 2 | 568 contacts → | ||||
Indirect evidence “Immatics is committed to making a meaningful impact on the lives of patients with cancer.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 3 | 155 contacts → | ||||
Indirect evidence “Miltenyi Biomedicine is a biopharmaceutical company that develops innovative cell and gene therapies.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 4 | 65 contacts → | ||||
Indirect evidence “Affimed N.V.(Nasdaq: AFMD) is a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer by actualizing the untapped potential…” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 5 | 60 contacts → | ||||
Indirect evidence “Medigene AG (FSE: MDG1) is a leading immuno-oncology platform company dedicated to developing T-cell therapies to effectively eliminate cancer.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 6 | 51 contacts → | ||||
Indirect evidence “iOmx is a young, dynamic start-up in the field of immuno-oncology located in Martinsried/Munich, Germany.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 7 | 27 contacts → | ||||
Partial evidence “Antibody-based immunotherapies have great potential for the treatment of tumor diseases.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 8 | 26 contacts → | ||||
Partial evidence “The Helmholtz Institute for Translational Oncology Mainz (HI-TRON Mainz) is a joint venture of the German Cancer Research Center (DKFZ) in cooperation with the Research Institute…” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 9 | 20 contacts → | ||||
Indirect evidence “Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s…” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 10 | 19 contacts → | ||||
Indirect evidence “At Panosome we are making the most challenging target classes such as carbohydrates, peptides and small molecules addressable to antibodies.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 11 | 18 contacts → | ||||
Indirect evidence “TME Pharma is a clinical-stage company focusing on developing novel therapies for treatment of the most aggressive cancers.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 12 | 12 contacts → | ||||
Partial evidence “T-CURX is a Biotech company, spun-out from the University Clinics Würzburg, Germany, developing first- and best-in-class personalized immunotherapies on the basis of CAR-T cells.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 13 | 11 contacts → | ||||
Indirect evidence “Thermosome is a clinical-stage drug development company focused on targeted tumor therapy combined with immune stimulation for improved cancer therapy.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 14 | 10 contacts → | ||||
Indirect evidence “Captain T Cell develops first-in-class, efficacy-enhanced T cell therapies against solid tumors that are not addressed by existing treatments.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 15 | 8 contacts → | ||||
Indirect evidence “KUPANDO is a pioneering biotech company developing disruptive therapies to address critical unmet medical needs with significant market potential in cancer and infectious diseases.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 16 | 4 contacts → | ||||
Indirect evidence “At EMUNO, we develop new drugs to control immunity, treat diseases, and enhance human health and wellbeing.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 17 | 4 contacts → | ||||
Indirect evidence “ActiTrexx GmbH is a new biotech start up and was founded in 2020.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 18 | 3 contacts → | ||||
Indirect evidence “therawis diagnostics GmbH is a privately held companywith offices located in Munich, Germany, and was founded together with clinicians and scientists of the Technical University…” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 19 | 2 contacts → | ||||
Indirect evidence “GEMoaB GmbH is a privately-owned, clinical-stage biopharmaceutical company based in Dresden, Germany, that is focused on becoming a leading, fully integrated biopharmaceutical…” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 20 | 1 contacts → | ||||
Partial evidence “Developing next generation immunotherapeutics until the stage of clinical evaluation; Research on host tumor interaction; novel antibodies and peptide vaccines” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 21 | 1 contacts → | ||||
Indirect evidence “LDG – Laboratories Dr.” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
| 22 | 1 contacts → | ||||
Strong evidence “Since 1998, Wellington Partners has been a leading European Venture Capital firm investing in early- and growth-stage Life Science companies, active in the fields of Therapeutics…” Source: RevenueBase Database · checked Sep 3, 2026Thanks. The Data Team will review it. | |||||
RevenueBase Smart Search
RevenueBase Smart Search assesses information from a company’s LinkedIn profile, information supplied directly by the company, its website, and other publicly available sources. It uses that information to rate how closely the company relates to this list’s category: immunotherapy venture capital companies. Every row carries its rating and the description the rating was read from, so each one can be checked rather than taken on trust.
- Strong evidence
- The company's own public description of its business names immunotherapy venture capital companies.
- Partial evidence
- Its own public description names part of immunotherapy venture capital companies, so it works in or next to the category without describing itself that way.
- Indirect evidence
- The description shown does not name immunotherapy venture capital companies. The match rests on the rest of the company's public profile rather than the one sentence quoted here, so this is the rating to check first.
RevenueBase Smart Search is how these lists are built: RevenueBase's data engine and AI assemble the companies that match a category defined in a user's own words, so a list can be about what companies actually do rather than about whichever industry code they were filed under.
Showing 22 of 48 immunotherapy venture capital companies based in Germany
See the full list, filter by size, metro and specialty, and get verified emails and direct dials for all 3,509 reachable decision-makers.
Free signup · no credit card
Immunotherapy venture capital companies based in Germany at a glance
As of Sep 3, 2026Companies by employee count
Freshness & accuracy
How recently the business emails on this list were verified
Email last verified
How this list was built
Company categories are rarely black and white. RevenueBase reads each company's own description of its business to decide whether it belongs among immunotherapy venture capital companies, so some rows will be adjacent to the category rather than pure plays. The description and RevenueBase Smart Search rating on every row are there so you can check each match yourself.
- Source
- The RevenueBase company graph: 60 million companies and 398.9 million professional contacts resolved from primary sources, queried with RevenueBase Smart Search, the natural-language company search available to every RevenueBase user.
- What qualifies
- Companies headquartered in Germany whose own description of what they do matches “immunotherapy venture capital companies”. Matching reads each company's description, not its industry code or its name.
- RevenueBase Smart Search
- RevenueBase Smart Search is how this list is assembled and how each row is rated. RevenueBase's data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to a category defined in a user's own words. Each row is rated strong evidence (its own description names immunotherapy venture capital companies), partial evidence (it names part of the category) or indirect evidence (the description shown names none of it and the match rests on the rest of the company's profile). The description supporting each rating is quoted on the row.
- What we exclude
- Companies whose own description does not clearly place them among immunotherapy venture capital companies, and records with no verified work email. Companies headquartered outside Germany are excluded even when they keep an office there.
- Match quality
- In blind human judging of this matching method, 86% of matched companies were on target. Expect roughly 1 in 7 rows to be adjacent to the category rather than a pure play. Every row shows the company's own description and its RevenueBase Smart Search rating so you can judge each match yourself. Read the full methodology: how the lists are built, how the judging worked, and what the figure means.
- Ranking
- Team size, largest first: companies are ordered by the number of professionals RevenueBase tracks at each one. Employee ranges shown are reported bands, for context.
- Verification
- Every listed company carries at least one verified work email, 3,509 across the full list. Contacts re-verify on a rolling cadence, and each contact's own verification date is shown inside RevenueBase.
- Refresh
- This page's figures were pulled from the company graph on September 3, 2026. Lists refresh periodically as the graph is re-checked.
- Corrections
- Wrong category, wrong headquarters, or a company that has closed? Use “Report an issue” on any row. Reports go to the RevenueBase Data Team and feed back into the company graph.
Frequently asked
What is RevenueBase Smart Search?
RevenueBase Smart Search is how RevenueBase decides which companies belong on this list and how strongly each one fits. Its data engine and AI assess a company's LinkedIn profile, information supplied directly by the company, its website and other publicly available information, then relate it to the category the list is about. Each row is rated strong evidence when the company's own description names immunotherapy venture capital companies, partial evidence when it names part of the category, and indirect evidence when the description shown names none of it and the match rests on the rest of the company's profile.
How many immunotherapy venture capital companies are there based in Germany?
RevenueBase identified 48 immunotherapy venture capital companies headquartered in Germany as of September 2026, matched on each company's own description of what it does rather than its industry code.
What is the largest company on this list?
Biontech SE, headquartered in Idar-Oberstein, tops this list with the largest team on record.
Which city has the most immunotherapy venture capital companies?
Munich leads with 7 headquartered companies, followed by Heidelberg (4) and Berlin (3).
How do I get contact information for these companies?
A free RevenueBase account lets you run this exact search and work the top results, verified emails and direct dials included. Upgrading unlocks all 3,509 verified decision-maker contacts tracked across these 48 companies.
How current is this list?
The list refreshes periodically as the company graph is re-checked. This page's figures were pulled on September 3, 2026.
Ready to reach these companies? Verified emails and direct dials for all 48 immunotherapy venture capital companies based in Germany. Start with a free account, no credit card.
Download this list →Related lists
Immunotherapy venture capital companies by geography
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia
- Immunotherapy venture capital companies based in Spain
- Immunotherapy venture capital companies based in London, United Kingdom
- Immunotherapy venture capital companies based in Boston, United States
- Immunotherapy venture capital companies based in Cambridge, United States
- Immunotherapy venture capital companies based in New York, United States
- Immunotherapy venture capital companies based in San Diego, United States
About this data
RevenueBase is a B2B data infrastructure company. Its company graph covers 60 million companies and 398.9 million professional contacts, with emails verified on a rolling cadence rather than scraped once and left to decay. These company lists are generated directly from that graph with RevenueBase Smart Search, the same natural-language company search every RevenueBase user has: describe a market in plain words, get the companies that match, and add verified emails and direct dials for the people at them. It is the same data that powers RevenueBase's B2B data products, and a free account includes 500 credits to start. How these lists are built and judged.
More company lists
- All company lists
- Lists by location
- Lists A-Z
- New lists
- Immunotherapy venture capital companies based in the United States
- Immunotherapy venture capital companies based in the United Kingdom
- Immunotherapy venture capital companies based in France
- Immunotherapy venture capital companies based in Canada
- Immunotherapy venture capital companies based in Switzerland
- Immunotherapy venture capital companies based in Australia